Absci Corporation EV/FCF

EV/FCF of ABSI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current EV/FCF of Absci Corporation is -0.51 (as of December 31, 2022)
  • EV/FCF for the quarter ending September 30, 2023 was -0.1 (a -55.82% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -79.79%
  • Annual EV/FCF for 2022 was -0.51 (a -66.53% decrease from previous year)
  • Annual EV/FCF for 2021 was -1.53 (a -81.17% decrease from previous year)
  • Annual EV/FCF for 2020 was -8.13 (a -0.0% decrease from previous year)
Visit stockrow.com/ABSI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Absci Corporation

Most recent EV/FCFof ABSI including historical data for past 10 years.

Interactive Chart of EV/FCF of Absci Corporation

Absci Corporation EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -0.1 -0.23 -0.25 – –
2022 -0.51 -1.07 -0.85 -4.58 -0.51
2021 -1.53 -7.44 -8.13 -8.13 -1.53
2020 -8.13 -8.13 -8.13 -8.13 -8.13
2019 – – – – -8.13

Business Profile of Absci Corporation

Sector: Healthcare
Industry: Biotechnology
© stockrow.com